Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, J. M.
Right arrow Articles by Walker, F. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, J. M.
Right arrow Articles by Walker, F. O.
NEUROLOGY 1988;38:961
© 1988 American Academy of Neurology

Evidence for a role of haloperidol-sensitive {sigma}-'opiate' receptors in the motor effects of antipsychotic drugs

J. M. Walker, PhD, R. R. Matsumoto, MA, W. D. Bowen, PhD, D. L. Gans, K. D. Jones and F. O. Walker, MD

From the Department of Psychology and Division of Biology and Medicine (Dr. J. M. Walker, Ms. Matsumoto, Dr. Bowen, Ms. Gans, and Mr. Jones), Brown University, Providence, RI; and the Department of Neurology (Dr. F. O. Walker), Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC.

Haloperidol exhibits a high affinity for a subclass of {sigma}-"opiate" binding sites which have a unique anatomic distribution and a unique drug selectivity pattern. These binding sites differ from phencyclidine-sensitive {sigma}-receptors and are found in many brain areas involved in the control of movement. 1,3-Di-o-tolylguanidine (DTG), a highly selective ligand for the haloperidol-sensitive {sigma}-receptor, produced marked dystonia in rats after micro injection into the red nucleus, a motor area rich in this receptor. Haloperidol and another {sigma}-ligand [(+)-SKF 10,047] produced similar effects. On the other hand, clozapine, an antipsychotic drug which fails to bind to {sigma}-receptors and fails to induce movement disorders in humans, failed to induce these dystonic reactions in rats. Phencyclidine was also without effect, as were injections of the active compounds in sites distant to the red nucleus. Microinjections of DTG in the substantia nigra produced vigorous contralateral circling behavior at extremely low doses. These findings suggest that {sigma}-binding sites represent biologically functional receptors that are active in the neural control of movement. Since haloperidol (and many other antipsychotic drugs) exhibit an affinity for {sigma}-receptors which is at least equal to its affinity for dopamine receptors, these data raise the further possibility that {sigma}-receptors are involved in the motor side effects of antipsychotic drugs.

Address correspondence and reprint requests to Dr. J. M. Walker, Walter S. Hunter Laboratory of Psychology, Brown University, Box 1853, Providence, RI 02912.

Supported by the Dystonia Medical Research Foundation, The Rhode Island Foundation, the Public Health Service (NS21745, DA07736), and Brown University.

Received July 2, 1987. Accepted for publication in final form October 15, 1987.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. E. Pizoli, H. A. Jinnah, M. L. Billingsley, and E. J. Hess
Abnormal Cerebellar Signaling Induces Dystonia in Mice
J. Neurosci., September 1, 2002; 22(17): 7825 - 7833.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J. L Janavs and M. J Aminoff
Dystonia and chorea in acquired systemic disorders
J. Neurol. Neurosurg. Psychiatry, October 1, 1998; 65(4): 436 - 445.
[Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Cohen, D. J. Sanger, and G. Perrault
Characterization of the Discriminative Stimulus Produced by the Dopamine Antagonist Tiapride
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 566 - 573.
[Abstract] [Full Text]


Home page
J PsychopharmacolHome page
B.E. Leonard and C.D. Nicholson
Sigma ligands as potential psychotropic drugs
J Psychopharmacol, January 1, 1994; 8(1): 64 - 65.
[PDF]


Home page
ScienceHome page
S Schwarz, P Pohl, and G. Zhou
Steroid binding at sigma-"opioid" receptors
Science, December 22, 1989; 246(4937): 1635 - 1637.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by AAN Enterprises, Inc.